Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emiko Rimbara

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Japanese Journal of Helicobacter Research|January 31, 2017
<i>Helicobacter pylori</i> Therapy in the WestDavid Y Graham, Emiko Rimbara
Journal of Clinical Gastroenterology|March 11, 2011
Understanding and appreciating sequential therapy for Helicobacter pylori eradicationDavid Y Graham, Emiko Rimbara
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2012
PCR detection of Helicobacter pylori in clinical samplesEmiko Rimbara, Masanori Sasatsu, David Y Graham
Microbiology and Immunology|October 24, 2007
Correlation between substitutions in penicillin-binding protein 1 and amoxicillin resistance in Helicobacter pyloriEmiko Rimbara, Norihisa Noguchi, Takashi Kawai, et al.
Helicobacter|January 7, 2012
Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrBEmiko Rimbara, Norihisa Noguchi, Takashi Kawai, et al.
Antimicrobial Agents and Chemotherapy|July 9, 2008
Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pyloriEmiko Rimbara, Norihisa Noguchi, Takashi Kawai, et al.
Microbiology and Immunology|August 14, 2013
Role of γ-glutamyltranspeptidase in the pathogenesis of Helicobacter pylori infectionEmiko Rimbara, Shigetarou Mori, Hyun Kim, et al.
Plos One|June 21, 2014
Biochemical characterization of quinolinic acid phosphoribosyltransferase from Mycobacterium tuberculosis H37Rv and inhibition of its activity by pyrazinamideHyun Kim, Keigo Shibayama, Emiko Rimbara, et al.
Nature Reviews. Gastroenterology & Hepatology|February 5, 2011
Optimal therapy for Helicobacter pylori infectionsEmiko Rimbara, Lori A Fischbach, David Y Graham
The Journal of Antimicrobial Chemotherapy|February 16, 2008
Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pyloriEmiko Rimbara, Norihisa Noguchi, Takashi Kawai, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Japanese Journal of Helicobacter Research|January 31, 2017
<i>Helicobacter pylori</i> Therapy in the WestDavid Y Graham, Emiko Rimbara
Journal of Clinical Gastroenterology|March 11, 2011
Understanding and appreciating sequential therapy for Helicobacter pylori eradicationDavid Y Graham, Emiko Rimbara
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2012
PCR detection of Helicobacter pylori in clinical samplesEmiko Rimbara, Masanori Sasatsu, David Y Graham
Microbiology and Immunology|October 24, 2007
Correlation between substitutions in penicillin-binding protein 1 and amoxicillin resistance in Helicobacter pyloriEmiko Rimbara, Norihisa Noguchi, Takashi Kawai, et al.
Helicobacter|January 7, 2012
Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrBEmiko Rimbara, Norihisa Noguchi, Takashi Kawai, et al.
Antimicrobial Agents and Chemotherapy|July 9, 2008
Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pyloriEmiko Rimbara, Norihisa Noguchi, Takashi Kawai, et al.
Microbiology and Immunology|August 14, 2013
Role of γ-glutamyltranspeptidase in the pathogenesis of Helicobacter pylori infectionEmiko Rimbara, Shigetarou Mori, Hyun Kim, et al.
Plos One|June 21, 2014
Biochemical characterization of quinolinic acid phosphoribosyltransferase from Mycobacterium tuberculosis H37Rv and inhibition of its activity by pyrazinamideHyun Kim, Keigo Shibayama, Emiko Rimbara, et al.
Nature Reviews. Gastroenterology & Hepatology|February 5, 2011
Optimal therapy for Helicobacter pylori infectionsEmiko Rimbara, Lori A Fischbach, David Y Graham
The Journal of Antimicrobial Chemotherapy|February 16, 2008
Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pyloriEmiko Rimbara, Norihisa Noguchi, Takashi Kawai, et al.
Pageof 6